Contact us for free information or to start a free case review.
Multaq® (dronedarone) was approved by the U.S. Food and Drug Administration (FDA) July 2, 2009, to treat the heart rhythm disorders atrial fibrillation and atrial flutter. The medication is meant to be used in patients whose heart rhythm has returned to a regular state or for patients about to have a drug or electric-shock treatment to restore a normal heartbeat.
The drug is manufactured by multinational corporation Sanofi-Aventis, which is based in Paris.
The adult dosage for Multaq® is one 400 mg tablet twice a day, once in the morning and once in the evening. No dosing information is available for children, who must see their doctor to be treated with Multaq®.
Patients with heart failure or recent hospitalization for the condition are warned not to take the medication because it may worsen their heart failure and increase the chance of dying. Patients are urged to call their doctor if they experience the following symptoms, indicative of worsening heart failure:
Patients are told to call their doctor if they experience any changes in their heart rhythm such as heartbeats that become:
Other reasons to call the doctor right away include:
Patients are told not to eat grapefruit or drink grapefruit juice while on the drug because this can increase the medication's side effects by increasing the amount of the drug in the body.
The most common side effects to Multaq® include upset stomach, diarrhea, weakness or loss of strength.
Less common side effects include:
Rare side effects include:
If you have suffered any serious side effects from Multaq®, we encourage you to contact a Multaq® lawyer right away as you may be entitled to compensation. Drug makers are required to protect a patient's safety. When a medication harms a patient, the company should be help liable. Our Multaq® attorneys would like to speak with you if you've suffered from heart failure, kidney problems, or other serious conditions while taking the heart medication.
The FDA notified healthcare professionals about new findings that link Multaq® to severe liver injuries, Jan. 14, 2011. The agency said there were two report...
Copyright © 2001 - 2012 Online Lawyer Source | Legal Marketing Site Designed by eJustice
ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.